JOHN MILLER: Open Payments
NPI 1427465483 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 5 payments from 5 companies in 2025. Trend: 2023 $26 · 2024 $64 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Luye Pharma (USA) Ltd. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: UZEDY, HETLIOZ, INGREZZA, ERZOFRI EXTENDED-RELEASE, COBENFY.
Industry payments across FL — which companies pay providers there.
